CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

Corbus Announces Dosing of First Patient in U.S. Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC

02 Apr 2024 08:01:11 By Nasdaq GlobeNewswire

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

13 Mar 2024 09:45:14 By NetDania Notify

Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update

12 Mar 2024 08:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

08 Mar 2024 10:25:24 By NetDania Notify

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

07 Mar 2024 10:12:48 By NetDania Notify

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

06 Mar 2024 09:45:06 By NetDania Notify

Corbus Pharmaceuticals to Participate in the BMO Capital Markets Inaugural Obesity Summit

06 Mar 2024 08:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

05 Mar 2024 10:02:57 By NetDania Notify

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

04 Mar 2024 11:25:20 By NetDania Notify

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

01 Mar 2024 09:48:44 By NetDania Notify

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

29 Feb 2024 14:30:15 By NetDania Notify

Corbus Pharmaceuticals Appoints Dr. Dominic Smethurst as Chief Medical Officer

28 Feb 2024 08:00:00 By Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

06 Feb 2024 09:50:36 By Nasdaq GlobeNewswire

Corbus Pharmaceuticals Announces Closing of $94.5 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares

02 Feb 2024 16:01:11 By Nasdaq GlobeNewswire

Corbus Pharmaceuticals Announces Pricing of Public Offering

31 Jan 2024 09:19:41 By Nasdaq GlobeNewswire

Corbus Pharmaceuticals Announces Proposed Public Offering

30 Jan 2024 18:55:29 By Nasdaq GlobeNewswire

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

26 Jan 2024 09:45:17 By NetDania Notify

CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting Antibody Drug Conjugate Demonstrates Encouraging Safety and Efficacy in Patients with Nectin-4 Positive Tumors in First-In-Human Study Presented at ASCO-GU 2024

26 Jan 2024 07:30:00 By Nasdaq GlobeNewswire

Phase 1 Clinical Data for SYS6002 (CRB-701) to be presented at 2024 ASCO GU

23 Jan 2024 08:00:00 By Nasdaq GlobeNewswire

Corbus Pharmaceuticals Announces FDA Clearance of IND Application for its anti-αvβ8 monoclonal antibody (CRB-601)

09 Jan 2024 08:00:00 By Nasdaq GlobeNewswire